Article Sidebar
Published:
Nov 3, 2015Article Details
http://www.sajp.org.za/index.php/sajp/pages/view/policies#part_4
Copyright
The author(s) retain copyright on work published by AOSIS unless specified otherwise.
Licensing and publishing rights
Author(s) of work published by AOSIS are required to grant AOSIS the unlimited rights to publish the definitive work in any format, language and medium, for any lawful purpose.
AOSIS requires journal authors to publish their work in open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
Read more here: http://creativecommons.org/licenses/by/4.0/.
The authors retain the non-exclusive right to do anything they wish with the published article(s), provided attribution is given to the applicable journal with details of the original publication, as set out in the official citation of the article published in the journal. The retained right specifically includes the right to post the article on the authors’ or their institution’s websites or in institutional repositories.
Previously published work may have been published under a different licence. We advise the community that if they would like to reuse the work to consult the applicable licence at article level.
Main Article Content
Views of schizophrenia patients on the effects of cannabis on their mental health
Abstract
Background. Cannabis use may trigger or perpetuate clinical features of schizophrenia in vulnerable individuals, thereby contributing to the morbidity of schizophrenia and its burden of disease. These findings have mostly not considered the views of schizophrenia patients on cannabis use and its effect on their mental health.
Methods. A semi-structured 16-point opinion-type questionnaire was formulated from the results of a previous qualitative study on schizophrenia patients’ opinions about cannabis use. The questionnaire was applied to 60 participants from an inpatient schizophrenia population at Weskoppies Hospital, Pretoria, South Africa, who had a Diagnostic and Statistical Manual of Mental Disorders, 4th edition (text revision) (DSM-IV-TR) diagnosis of schizophrenia and a documented history of cannabis use.
Results. According to participants’ responses, 61.7% admitted to suffering from a mental illness, 95.0% admitted to using cannabis in the past, and 20.0% of participants admitted to the current use of cannabis. Over half (51.7%) of the participants responded that cannabis had adverse effects on their mental health, 26.7% that their mental illness was caused by using an illicit drug other than cannabis, 26.7% that only impure cannabis had adverse effects on their mental health, and 48.3% that only using too much cannabis had bad effects on their mind. A high percentage (58.3%) of participants responded that cannabis use helped reduce tension, 56.7% that it helped reduce anxiety, 66.7% that it helped to lift their mood, 63.3% that it helped them to relax, 60.0% that it helped to relieve their boredom, 43.3% that it helped them feel more energetic, 58.3% that it helped them sleep better, 13.3% that it helped reduce auditory hallucinations, and 31.7% that the beneficial effects of cannabis outweighed its negative effects.
Conclusion. Most of the participants who responded that they were not using cannabis currently had positive views about its effects on their mental health, despite responding that cannabis may have adverse effects on their mental health. This is a worrisome outcome, since those participants who feel that cannabis has more beneficial than detrimental effects might not remain abstinent.
